Middle East And Africa Surgical Site Infection Control Market Growth Prospects 2024-2032
Triton’s research report states that the Middle East and Africa surgical site infection control market is estimated to register a CAGR of 4.56% during the forecast period 2024-2032.
The surgical site infection (SSI) control market’s development in the Middle East and Africa (MEA) is accelerated by rising healthcare awareness, government initiatives, and international collaborations aimed at improving healthcare infrastructure. The World Health Organization (WHO) and various regional health ministries have been actively involved in initiatives to reduce SSIs, which are a significant cause of morbidity and mortality. In countries like Saudi Arabia and South Africa, there has been a significant push towards improving hospital hygiene and infection control measures supported by government funding and international partnerships.
The countries analyzed in this region are UAE, South Africa, Israel, Turkey, and Rest of Middle East & Africa.
Saudi Arabia leads the regional market, obtaining $66.9 million in 2023
- The growth of the surgical site infection control market in Saudi Arabia is strongly driven by the government’s Vision 2030 initiative, which aims to modernize the healthcare sector and improve patient safety.
- The Saudi Ministry of Health has implemented stringent guidelines and infection control protocols in hospitals to reduce the incidence of surgical site infections (SSIs). The introduction of advanced sterilization techniques, antimicrobial dressings, and preventive measures are increasingly being adopted across healthcare facilities.
- The Saudi Centers for Disease Control and Prevention (Saudi CDC) provides specific guidelines for SSI prevention, including the use of prophylactic antibiotics, proper hand hygiene, and enhanced sterilization protocols. These guidelines have been widely adopted, leading to increased demand for infection control products and technologies.
Market Forecast for Turkey
In Turkey, the surgical site infection (SSI) control market is fueled by healthcare awareness and government initiatives aimed at improving patient safety. In 2022, surgical site infections remained a critical concern for Turkey’s healthcare system, particularly in procedures like cesarean sections and other high-frequency surgeries. The Ministry of Health in Turkey has been actively working on reducing healthcare-associated infections through various programs, including mandatory infection control measures in hospitals and the implementation of international best practices. The market is further supported by the increasing number of hospitals and the growing use of minimally invasive surgeries, which require stringent infection prevention measures.
The market segmentation includes industry vertical, procedure, type of infection, and product. The industry vertical section consists of hospitals and ambulatory surgical centers.
Surgical site infections (SSIs) account for approximately 15% of all hospital-acquired infections, making them the most common infection among surgical patients. These infections significantly extend postoperative hospital stays, increase healthcare costs, elevate the likelihood of readmission, and compromise patient outcomes. SSIs, which occur at or near surgical incisions within 30 days after surgery, contribute heavily to surgical complications and mortality annually.
Contender Analysis in the Surgical Site Infection Control Market:
3M is a diversified technology firm with operations across multiple industries, including industrial, safety and graphics, electronics and energy, healthcare, and consumer markets. Headquartered in Saint Paul, Minnesota, 3M has a global presence in the United States, Europe, the Middle East and Africa (EMEA), and the Asia Pacific. The company operates through five main business segments: industrial, safety and graphics, health care, electronics and energy, and consumer. The company also specializes in precision grinding technology for intricate industrial applications, and it develops advanced technical ceramics for use in sectors like automotive, oil and gas, solar, electronics, and defense.
Other companies in the market consist of American Polyfilm Inc, Ansell Limited, Belimed Life Science AG, and Gama Healthcare.
MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032.pdf